MNK


Mallinckrodt Files For Bankruptcy To Cut Debt, Settle Opioid Legal Claims

Mallinckrodt announced on Monday that it has voluntarily filed for Chapter 11 proceedings in a move to restructure its debt and resolve “several billions …

Mallinckrodt PLC (MNK) Soars on Back of 4Q Acthar Sales That Impressed Wall Street

Mallinckrodt PLC (NYSE:MNK) shares are rocketing a nice 16% after the drug maker unleashed a fourth quarter print that has left Wall Street …

Mallinckrodt PLC (MNK) Boasts 84% Upside Potential After Making a Well-Played Grab for Sucampo

Cantor’s Louise Chen sees two late-stage rare assets gained from MNK’s takeover of Sucampo poised for positive outcomes.

We Like This Mallinckrodt PLC (MNK) Deal to Take Over Sucampo, Cheers Louise Chen

Cantor’s Louise Chen finds MNK’s choice to acquire Sucampo not only an impressive way to close out 2017, but a move that shifts the company’s story beyond leading asset Acthar’s reimbursement challenges.

Dewey Steadman Is Playing it Cautiously Optimistic on Mallinckrodt PLC (MNK) on Back of Strategic Decision to Acquire Sucampo

Canaccord’s Dewey Steadman is positive on the “ideal” Sucampo deal and notes that unlike other pipeline-driven takeovers, short-term profit opportunities will likely content MNK investors.

Mallinckrodt PLC (MNK): Don’t Try to Catch a Falling Knife

Canaccord deems crashing MNK shares an overreaction, but cuts price target down over a third.

Mallinckrodt PLC (MNK) Inomax Sales to Reach $505.9 Million by 2017 Despite Losing Patent Battle: Cantor

Solid MNK business model will eventually attract investors, says analyst.

Mizuho Remains Buyer of Mallinckrodt PLC (MNK) Following F4Q:16 Results

In a research report published Wednesday, Mizuho Securities analyst Irina Rivkind Koffler reiterated a Buy rating on shares of Mallinckrodt PLC (NYSE:MNK) with …

Stock News: Apple Inc. (AAPL), Amazon.com, Inc. (AMZN), Mallinckrodt PLC (MNK), Signet Jewelers Ltd. (SIG)

Apple Inc. (NASDAQ:AAPL) is in the beginning stages of developing a video sharing product.

Nomura Weighs In on Valeant Pharmaceuticals Intl Inc (VRX) and Mallinckrodt PLC (MNK) Ahead of Earnings; Reiterates Mixed Ratings

As we head into 4Q15 earnings with the biotech sector, Nomura’s healthcare analyst Shibani Malhotra weighed in today on a handful of biotechnology stocks. Among …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts